In both human and animal patients, TP53 overexpression, primarily assessed by IHC techniques in tumor tissues, is linked to poor prognosis and tumor progression confirming the usefulness of this oncogene as a tumor biomarker (43–46). The gene discussed is TP53; the disease is neoplasm.